Genomic study of taste perception genes in African Americans reveals SNPs linked to Alzheimer's disease.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Original Publication: London : Nature Publishing Group, copyright 2011-

Alzheimer Disease*/genetics ; Polymorphism, Single Nucleotide* ; Black or African American*/genetics ; Genome-Wide Association Study* ; Taste Perception*/genetics ; Quantitative Trait Loci*; Humans ; Female ; Male ; Aged ; Genetic Predisposition to Disease ; Middle Aged ; Transcriptome

While previous research has shown the potential links between taste perception pathways and brain-related conditions, the area involving Alzheimer's disease remains incompletely understood. Taste perception involves neurotransmitter signaling, including serotonin, glutamate, and dopamine. Disruptions in these pathways are implicated in neurodegenerative diseases. The integration of olfactory and taste signals in flavor perception may impact brain health, evident in olfactory dysfunction as an early symptom in neurodegenerative conditions. Shared immune response and inflammatory pathways may contribute to the association between altered taste perception and conditions like neurodegeneration, present in Alzheimer's disease. This study consists of an exploration of expression-quantitative trait loci (eQTL), utilizing whole-blood transcriptome profiles, of 28 taste perception genes, from a combined cohort of 475 African American subjects. This comprehensive dataset was subsequently intersected with single-nucleotide polymorphisms (SNPs) identified in Genome-Wide Association Studies (GWAS) of Alzheimer's Disease (AD). Finally, the investigation delved into assessing the association between eQTLs reported in GWAS of AD and the profiles of 741 proteins from the Olink Neurological Panel. The eQTL analysis unveiled 3,547 statistically significant SNP-Gene associations, involving 412 distinct SNPs that spanned all 28 taste genes. In 17 GWAS studies encompassing various traits, a total of 14 SNPs associated with 12 genes were identified, with three SNPs consistently linked to Alzheimer's disease across four GWAS studies. All three SNPs demonstrated significant associations with the down-regulation of TAS2R41, and two of them were additionally associated with the down-regulation of TAS2R60. In the subsequent pQTL analysis, two of the SNPs linked to TAS2R41 and TAS2R60 genes (rs117771145 and rs10228407) were correlated with the upregulation of two proteins, namely EPHB6 and ADGRB3. Our investigation introduces a new perspective to the understanding of Alzheimer's disease, emphasizing the significance of bitter taste receptor genes in its pathogenesis. These discoveries set the stage for subsequent research to delve into these receptors as promising avenues for both intervention and diagnosis. Nevertheless, the translation of these genetic insights into clinical practice requires a more profound understanding of the implicated pathways and their pertinence to the disease's progression across diverse populations.
(© 2024. The Author(s).)

Update of: bioRxiv. 2024 Aug 10:2024.08.10.607452. doi: 10.1101/2024.08.10.607452. (PMID: 39372803)

Int Psychogeriatr. 2016 Mar;28(3):511-7. (PMID: 26423603)
Alzheimers Dement (N Y). 2018 Sep 06;4:575-590. (PMID: 30406177)
Mol Psychiatry. 2013 Aug;18(8):943-50. (PMID: 23628982)
Front Immunol. 2019 Jul 04;10:1473. (PMID: 31333644)
Front Pharmacol. 2019 Sep 12;10:1008. (PMID: 31572186)
Physiol Rev. 2022 Oct 1;102(4):1587-1624. (PMID: 35468004)
Exp Neurol. 2022 May;351:113994. (PMID: 35114205)
J Biol Chem. 2013 Aug 2;288(31):22248-56. (PMID: 23782696)
Nat Rev Neurosci. 2008 Jan;9(1):46-56. (PMID: 18073775)
Nat Genet. 2022 Apr;54(4):412-436. (PMID: 35379992)
Biochem Biophys Res Commun. 2010 Jan 1;391(1):147-51. (PMID: 19903456)
Nat Genet. 2013 Dec;45(12):1452-8. (PMID: 24162737)
J Gen Physiol. 2017 Feb;149(2):181-197. (PMID: 28053191)
Adv Otorhinolaryngol. 2006;63:255-264. (PMID: 16733343)
J Neurol. 2010 Feb;257(2):238-46. (PMID: 19727902)
Cell. 2009 Oct 16;139(2):234-44. (PMID: 19837029)
Adv Child Dev Behav. 1979;13:257-95. (PMID: 484324)
Oxid Med Cell Longev. 2022 Aug 28;2022:6038996. (PMID: 36071869)
Sci Rep. 2023 Nov 2;13(1):18895. (PMID: 37919307)
Transl Psychiatry. 2018 May 18;8(1):99. (PMID: 29777097)
Curr Opin Physiol. 2021 Apr;20:70-76. (PMID: 33738371)
Nat Rev Mol Cell Biol. 2016 Apr;17(4):240-56. (PMID: 26790531)
Bioinformatics. 2012 May 15;28(10):1353-8. (PMID: 22492648)
Nutrients. 2019 Aug 28;11(9):. (PMID: 31466230)
Nature. 2006 Nov 16;444(7117):288-94. (PMID: 17108952)
Int J Mol Sci. 2022 Dec 21;24(1):. (PMID: 36613519)
Semin Cell Dev Biol. 2012 Feb;23(1):75-82. (PMID: 22040917)
Eur J Hum Genet. 2019 Apr;27(4):594-602. (PMID: 30659260)
Genome Biol. 2010;11(3):R25. (PMID: 20196867)
Annu Rev Pharmacol Toxicol. 2018 Jan 6;58:429-449. (PMID: 28968187)
Dement Geriatr Cogn Dis Extra. 2017 Nov 23;7(3):395-405. (PMID: 29430242)
Acta Physiol (Oxf). 2016 Apr;216(4):407-20. (PMID: 26493384)
Cancers (Basel). 2021 Nov 23;13(23):. (PMID: 34885005)
Inflammopharmacology. 2023 Feb;31(1):89-117. (PMID: 36471190)
CNS Neurosci Ther. 2011 Oct;17(5):514-24. (PMID: 20553310)
Biochem Pharmacol. 2020 Jul;177:113954. (PMID: 32251676)
Front Genet. 2022 Oct 11;13:952299. (PMID: 36303543)
Curr Allergy Asthma Rep. 2019 Sep 5;19(10):48. (PMID: 31486942)
Neurobiol Aging. 2002 May-Jun;23(3):397-404. (PMID: 11959402)
Nucleic Acids Res. 2023 Jan 6;51(D1):D977-D985. (PMID: 36350656)
J Dent Res. 2022 Jul;101(7):759-768. (PMID: 35191336)
Curr Nutr Rep. 2019 Jun;8(2):108-119. (PMID: 30945140)
Nat Genet. 2019 Mar;51(3):404-413. (PMID: 30617256)
Physiol Behav. 2011 Nov 30;105(1):4-13. (PMID: 21324331)
J Transl Med. 2021 Oct 21;19(1):440. (PMID: 34674725)
Arch Gen Psychiatry. 2012 Aug;69(8):776-86. (PMID: 22474070)
Lancet Neurol. 2017 Jun;16(6):478-488. (PMID: 28504111)
Exp Brain Res. 2005 Oct;166(3-4):345-57. (PMID: 16028032)
Pharmacol Res. 2021 May;167:105557. (PMID: 33737243)
Alzheimers Dement. 2019 Oct;15(10):1333-1347. (PMID: 31473137)
Mol Neurodegener. 2023 Jan 7;18(1):2. (PMID: 36609403)
Front Pharmacol. 2019 Oct 28;10:1282. (PMID: 31719824)
Biochem Pharmacol. 2022 Mar;197:114915. (PMID: 35051386)
Signal Transduct Target Ther. 2017;2:. (PMID: 29158945)
Alzheimers Dement. 2022 Aug;18(8):1461-1471. (PMID: 34854531)
Cell Death Dis. 2023 May 6;14(5):309. (PMID: 37149633)
Biol Res Nurs. 2021 Apr;23(2):223-230. (PMID: 32799655)
Nat Rev Neurosci. 2015 May;16(5):305-12. (PMID: 25873042)
OMICS. 2018 Jul;22(7):493-501. (PMID: 30004846)
BMC Genomics. 2014 Dec 03;15:1057. (PMID: 25471201)

Keywords: African American; Alzheimer’s disease; GWAS; Proteome; Taste genes; Transcriptome

Date Created: 20240916 Date Completed: 20240916 Latest Revision: 20241010

20241011

PMC11405524

10.1038/s41598-024-71669-9

39284855